Home https://server7.kproxy.com/servlet/redirect.srv/sruj/smyrwpoii/p2/ US https://server7.kproxy.com/servlet/redirect.srv/sruj/smyrwpoii/p2/ Christie gained access to experimental treatments with COVID-19

Christie gained access to experimental treatments with COVID-19

  • The former governor of New Jersey warns Americans to take COVID-19 seriously.
  • Christie said he tested positive for the virus earlier this month and said he spent seven days in the intensive care unit.
  • He also took remdezivir and an anti-body cocktail from Eli Lilly, experimental therapies that are not yet fully approved or available to the general American public.
  • Visit the Business Insider homepage for more stories.

Chris Christie revealed that he spent seven days in intensive care and received experimental therapies after being diagnosed with COVID-19 – and now encourages all Americans to take COVID-1

9 seriously.

In a statement, Christie also said he took remdezivir and an anti-body cocktail from Eli Lilly, which is still in experimental trials. (The National Institutes of Health survey was stopped this week due to safety concerns.)

Christie was among a number of people close to President Donald Trump who were positive for the virus earlier this month. The former governor of New Jersey was also one of a dozen people with positive tests who attended the Rose Garden event on Sept. 26 to announce Trump’s Amy Connie Barrett nomination to the Supreme Court.

He told The New York Times on Thursday that he was “wrong” not to wear a mask at the White House and with the president.

“I believed that when I entered White House territory, that I had entered a safe zone because of the tests that I and many others took every day. that I did not wear a mask at my numerous sessions in preparation for debates with the president and the rest of the team, “Christie said in a statement.

He thanked his doctors and “the manufacturers of Remdesivir and the monoclonal anti-body cocktail Eli Lilly for giving me access to their emergency treatments.”

Remdezivir is an antiviral drug that has been shown to help hospitalized patients with COVID-19 recover faster. The Food and Drug Administration has issued an emergency permit for the use of the drug in hospitalized patients.

Antibody cocktails have not yet been approved by the FDA. Trump was also treated with remdezivir and another Regeneron antibody cocktail.

Christie and Trump had access to experimental therapies that are not available to most Americans. More than 8 million Americans have already contracted the coronavirus that causes COVID-19, and more than 218,000 have died.

Although there are factors that can help determine a person’s susceptibility to serious illness, there is no way to know exactly how this virus will affect each individual, and there is not enough evidence to prove that these therapies are completely effective.

A study of more than 2,750 patients with COVID-19 by the World Health Organization found that remdezivir had “little or no effect” on survival.

“These regimens of remdezivir, hydroxychloroquine, lopinavir and interferon appear to have little or no effect on hospitalized COVID-19, as indicated by overall mortality, initiation of ventilation and length of hospital stay,” the report, which has not been reviewed, states.

Christie also acknowledged that the virus can have different effects on different people and that everyone should take it seriously.

“No one should be happy to get the virus and no one should be more cavalier when it comes to infecting or infecting others,” Christie said. “This is something that must be taken very seriously. The consequences are wildly accidental and potentially deadly.”

ChargingSomething is loading.

Source link